*Refresh the page if the below document does not appear.
The US Food and Drug Administration (USFDA) issued six observations to Cipla, a major pharmaceutical company, following an inspection of its Goa plant in August 2022.
In order to stop selling ranitidine under the brand name “Zintac, ” Glaxosmithkline Pharmaceuticals has sent cease and desist letters to Akums Drugs and Pharmaceuticals (ADPL) and its affiliate Nicholas Healthcare.
A pharmaceutical company was issued a spot fine of Rs. 25,000 by the Indore Municipal Corporation for allegedly leaving medical waste lying around in the open.
Desvenlafaxine Extended-Release Tablets, 25 mg, have been made available by Lupin today after receiving approval from the US Food and Drug Administration (FDA).
Glenmark Pharmaceuticals Limited shareholders will be paid 2.50 per share on October 27th. Due to this payment, the dividend yield will be 0.7%, which is lower than the sector average.
Takeda Pharmaceutical and Finch Therapeutics’ microbiome partnership is coming to an end without either of the two joint inflammatory bowel disease research programs making it to human testing.
The German pharmaceutical company Bayer
AG has begun pivotal late-stage studies of a
new thrombosis prevention drug as it works to
update a portfolio that is being threatened by
low-cost generic competition.